Pharmacist participation on an HIV resource team

Weingarten, Cindy M.; Freeland, Barbara

doi:10.1093/ajhp/52.12.1282

Cited by 5 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These and other studies5,6 demonstrate the importance of the pharmacist’s medication expertise and involvement in the multidisciplinary care team. Most recently, Horberg et al7 examined the components of the HIV multidisciplinary care team that are associated with the greatest increases in ARV adherence.…”

Section: Introductionsupporting

confidence: 52%

The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review

Saberi¹,

Dong²,

Johnson³

et al. 2012

PPA

View full text Add to dashboard Cite

ObjectiveDue to the rapid proliferation of human immunodeficiency virus (HIV) treatment options, there is a need for health care providers with knowledge of antiretroviral therapy intricacies. In a HIV multidisciplinary care team, the HIV pharmacist is well-equipped to provide this expertise. We conducted a systematic review to assess the impact of HIV pharmacists on HIV clinical outcomes.MethodsWe searched six electronic databases from January 1, 1980 to June 1, 2011 and included all quantitative studies that examined pharmacist’s roles in the clinical care of HIV-positive adults. Primary outcomes were antiretroviral adherence, viral load, and CD4+ cell count and secondary outcomes included health care utilization parameters, antiretroviral modifications, and other descriptive variables.ResultsThirty-two publications were included. Despite methodological limitation, the involvement of HIV pharmacists was associated with statistically significant adherence improvements and positive impact on viral suppression in the majority of studies.ConclusionThis systematic review provides evidence of the beneficial impact of HIV pharmacists on HIV treatment outcomes and offers suggestions for future research.

show abstract

Section: Introductionsupporting

confidence: 52%

The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review

Saberi¹,

Dong²,

Johnson³

et al. 2012

PPA

View full text Add to dashboard Cite

show abstract

HIV clinical pharmacists – the US perspective

Scott

Abernathy

Diaz-Linares

et al. 2010

Farmacia Hospitalaria

View full text Add to dashboard Cite

Clinical pharmacists have been involved in treating people with HIV and AIDS since the epidemic began. Their roles have evolved from inpatient infectious diseases training clinical pharmacists offering treatment regimens for the serious opportunistic infections seen in the hospital, to clinical pharmacists who received specialized training in the treatment of people with HIV in the ambulatory care setting. Their roles and benefits have been documented in the literature, but not to a large extent. Improvements in adherence and cost savings have been seen, but significant improvements in clinical outcomes (changes in viral load and CD4 cell counts) are quite complex and often difficult to identify in the small studies that have been published. This manuscript will review the published data on this topic, and provide examples of clinically trained pharmacists in the US who focus on the treatment of people with HIV infection. The pharmacists discussed here practice in a variety of settings (privately managed free-clinics and government managed clinics), take care of a variety of types of patients (children, adults, military veterans, lower socio-economic groups, etc.), and are employed by a variety of institutions (academic, pharmaceutical company, large healthcare systems and small healthcare systems). These pharmacists were chosen to be representative of the wide variety of individuals, positions and roles of clinical pharmacists involved in the treatment of HIV in the US.

show abstract